Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Data to Support Drug Product Communications, 22970 [2021-09043]

Download as PDF 22970 Federal Register / Vol. 86, No. 82 / Friday, April 30, 2021 / Notices ANNUAL BURDEN ESTIMATES Instrument Number of respondents (total over request period) Number of responses per respondent (total over request period) Avg. burden per response (in hours) Total/annual burden (in hours) Teaching staff survey ...................................................................................... 1,120 1 .50 560 Estimated Total Annual Burden Hours: 560. Comments: The Department specifically requests comments on (a) whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Consideration will be given to comments and suggestions submitted within 60 days of this publication. Authority: § 658O(a)(5) as amended by the CCDBG Act of 2014 § 9 Flint North, 10A–12M, 11601 Landsdown St., North Bethesda, MD 20852, 301–796–7726, PRAStaff@ fda.hhs.gov. On February 2, 2020, the Agency submitted a proposed collection of information entitled ‘‘Data to Support Drug Product Communications’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0695. The approval expires on March 31, 2024. A copy of the supporting statement for this information collection is available on the internet at https://www.reginfo.gov/ public/do/PRAMain. SUPPLEMENTARY INFORMATION: Dated: April 26, 2021. Lauren K. Roth, Acting Principal Associate Commissioner for Policy. Mary B. Jones, ACF/OPRE Certifying Officer. [FR Doc. 2021–09052 Filed 4–29–21; 8:45 am] BILLING CODE 4184–73–P [FR Doc. 2021–09043 Filed 4–29–21; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2014–N–0345] National Institutes of Health Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Data to Support Drug Product Communications National Institute of Dental & Craniofacial Research; Notice of Closed Meeting Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA or Agency) is announcing that a collection of information entitled ‘‘Data to Support Drug Product Communications’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (PRA). FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 20:36 Apr 29, 2021 Jkt 253001 Dated: April 26, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–09041 Filed 4–29–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES AGENCY: Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; End the HIV Epidemic. Date: May 28, 2021. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Yun Mei, MD, Scientific Review Officer, Scientific Review Branch, Natl Institute of Dental and Craniofacial Research, National Institutes of Health, 6701 Democracy Boulevard, Suite #670, Bethesda, MD 20892, (301) 827–4639, yun.mei@ nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 National Institute on Aging; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Initial Review Group Career Development Facilitating the Transition to Independence. Date: June 10–11, 2021. Time: 10:00 a.m. to 6:00 p.m. E:\FR\FM\30APN1.SGM 30APN1

Agencies

[Federal Register Volume 86, Number 82 (Friday, April 30, 2021)]
[Notices]
[Page 22970]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09043]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-0345]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Data to Support Drug Product 
Communications

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing 
that a collection of information entitled ``Data to Support Drug 
Product Communications'' has been approved by the Office of Management 
and Budget (OMB) under the Paperwork Reduction Act of 1995 (PRA).

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-7726, 
[email protected].

SUPPLEMENTARY INFORMATION: On February 2, 2020, the Agency submitted a 
proposed collection of information entitled ``Data to Support Drug 
Product Communications'' to OMB for review and clearance under 44 
U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0695. 
The approval expires on March 31, 2024. A copy of the supporting 
statement for this information collection is available on the internet 
at https://www.reginfo.gov/public/do/PRAMain.

    Dated: April 26, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-09043 Filed 4-29-21; 8:45 am]
BILLING CODE 4164-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.